Nantenine alkaloid presents anticonvulsant effect on two classical animal models.
The present study investigated the anticonvulsant and convulsant profiles of nantenine, an aporphine alkaloid found in several vegetal species. At lower doses (20-50 mg/kg, i.p) the alkaloid proved to be effective in inhibiting pentylenotetrazol- (PTZ 100 mg/kg, s.c) and maximal electroshock-induced seizures (80 mA, 50 pulses/s, 0.2 s), suggesting its potential as an anticonvulsant drug. However, at higher doses ([greater than or equal to] 75 mg/kg, i.p) a convulsant activity was observed. Comparing the present in vivo nantenine effects on seizures with previous in vitro biphasic action on [Na.sup.+], [K.sup.+]-ATPase activity, the convulsant effect appears to be related to inhibition of these phosphatase at high doses whereas anticonvulsant effect, observed at low doses, seems attributable to its stimulation and the resultant decrease of [Ca.sup.2+]-influx into the cell.
Key words: Nantenine, Aporphine, Alkaloid, Anticonvulsant activity, Convulsant activity
The aporphine alkaloids are derivable from the benzyltetrahydroisoquinolines by the abstraction of two hydrogens in a such a manner that the two benzene nuclei form part of a 9,10-dihydrophenanthrene. The aporphine occurs most abundantly in the Papaveraceae, but they are also widespread in Anonaceae, Lauraceae and Moniminaceae families (Manske, 1954).
Derivatives of the aporphine molecule comprise pharmacologically active compounds such as apomorphine, an agonist of dopamine receptors, and alkaloids with antidopaminergic actions such as the bulbocapnine, boldine and glaucine (Zetler, 1988).
Besides their recognized dopaminergic effects, the aporphines still presents antagonistic activities on [alpha]1-adrenergic (Ivorra, 1993a; Baldessarini et al., 1994) and 5-H[T.sub.2]-serotonergic receptors (Alzueta et al., 1992; Catret et al., 1992), and blocking activity on voltage-dependent channels of calcium (Anselmi et al., 1991; Ivorra et al., 1992, 1993a, b). Other compounds structurally related to the aporphines, as the benzyltetrahydroisoquinolines (cularine, isocrasifoline and laudanosine) and the bisbenzyltetrahydroisoquinolines (antioquine, tetrandine) are also described as inhibitors of the C[a.sup.+2] influx through voltage-operated calcium channels (Ivorra et al., 1992, 1993a). The blocking activity of calcium channels increases furthermore the therapeutic potentiality of the aporphine alkaloid group.
Nantenine is an aporphine alkaloid found in several vegetal species. It was first isolated by Takase and Ohashi (1926) from fruit of Nandina domestica Thunberg, which was used to treat asthma, whooping cough, pharynx tumor and uterine bleeding in Japan for many years. Pharmacological studies showed that it shares some of the activities of the other aporphines, as well as of calcium channels blocking agents. In vitro assays demonstrated that the alkaloid, in small doses, antagonizes the contractions induced by [alpha]1-adrenergic an 5H[T.sub.2]-serotonergic agonists (Shoji et al., 1984; Alzueta et al., 1992) and that, as it happens with the calcium channel blockers, causes bradicardia and negative inotropism (Takase and Ohashi, 1926).
As regards nantenine effects on the central nervous system, contrasting actions according to the dose have been reported. Nantenine exerts a sedative effect at low doses whereas induces ataxia and convulsions at high doses (Takase and Ohashi, 1926).
Considering the anticonvulsant potential of calcium channel blockers (Meyer et al., 1986; Czuczwar et al., 1990a, b; Kamal et al., 1990) and the importance of natural products as sources of new drugs (Phillipson, 1979), the present experiments were designed to investigate the effect of nantenine on two classical models for anticonvulsant activity. The convulsant activity previously observed at high doses was also investigated.
* Materials and Methods
Male albino mice weighing 30-35 g were used. They were housed under controlled conditions of light (7:00-19:00 h), temperature (22 [+ or -] 2 [degrees]C) and humidity (60%) with food and water ad libitum. Animals used in this study were maintained in accordance with the guidelines of the Committee on Care an Use of Laboratory Animals Resources, National Research Council, USA.
Drugs and Chemical
Sodium chloride (Merck S.A. Industrias Quimicas), valproic acid (Abbot Laboratorios do Brasil), baclofen (Biogalenica Quimica e Farmaceutica Ltda--CibaGeigy), diazepam (Roche Produtos Quimicos e Farmaceuticos), phenobarbital (Rhodia Produtos Quimicos e Farmaceuticos), pentylenetetrazol (Sigma Chemical Co., USA) and diphenylhydantoin (Sarsa Laboratorio Silva Araujo-Roussel) were used. Nantenine was kindly provided by Professors Otto R. Gottlieb and Massayoshi Yoshida, Instituto de Quimica da Universidade de Sao Paulo, Brazil.
Nantenine dilution was made in a HCl 0.01N solution and the pH was adjusted to 5.0-5.5 with NaOH 0.1N.
All tests were carried out in a quiet room between 9:00 and 17:00 h. Thirty minutes before the tests, groups of 10 mice were treated with nantenine 10, 25, 40, 50 mg/kg, body w. (i.p), diphenylhydantoin 25 mg/kg, body w. (i.p.) or saline (NaCl 0.9%, i.p., 0.1 ml/10 g, v/w). For induction of maximal electroshock seizures (MES), a 80 Hz variable current (mA), 50 pulses/s frequency and 0.2 s duration (previously determined as 99.9% effective), was applied auricularly. Flexion time of front limbs, extension time of hind limbs and the number of deaths were registered and used to calculate the ratio extensor:flexor time and mortality rate, respectively (Swinyard, 1972). The effect of nantenine 10, 25, 40, 50 mg/kg body w., (i.p) or saline (NaCl 0.9%, i.p., 0.1 ml/10 g, v/w) on chemically induced seizures was investigated by injecting pentylenetetrazol (100 mg/kg, body w., s.c) in pretreated mice (Chen et al., 1954; Swinyard and Kupferberg, 1985). The animals were placed, individually, in glass beakers and their behavioral responses were recorded during thirty minutes. Clonus (at least 3s of continuous limb movement), tonus (complete hind limb extension) and mortality were recorded in terms of seizure percentage and latency.
Groups of 10 mice were pretreated with valproic acid 375 mg/kg body w. (i.p), diazepam 2.5 mg/kg body w. (i.p) phenobarbital 30 mg/kg body w. (i.p), baclofen 20 mg/kg (i.p) or saline (NaCl 0.9%, i.p, 0.1ml/10g, v/w) thirty minutes before receiving nantenine 105 mg/kg body w. (i.p) (a dose previously determined as 100% convulsant). The animals were placed, individually, in glass beakers and their behavioral responses were recorded during thirty minutes. Clonus (at least 3s of continuous limb movement), tonus (complete hind limb extension) and mortality were recorded in terms of seizure percentage and latency.
Extensor:flexor ratio and latency to convulsive episode results were submitted to Kruskal-Wallis non-parametric variance analysis followed by Mann-Whitney U test. Fisher's exact test was performed to determine significance of other anticonvulsant and convulsant properties results. Significance was set at p < 0.05.
Electroshock Maximal Seizures
Except for the dose of 10 mg/kg, body w., nantenine (20, 40 and 50 mg/kg, body w.) pretreatment significantly reduced extensor:flexor ratio and mortality in animals submitted to electroconvulsive shock (Fig. 1). At higher doses, 40 and 50 mg/kg, the percentage of death in tonic was reduced to zero. On these experimental conditions, diphenylhydantoin 25 mg/kg, body w. totally inhibited the electroshock-induced seizure (data not shown).
[FIGURE 1 OMITTED]
Pentylenetetrazol induced seizures
None of the tested doses (10, 20, 40 and 50 mg/kg, body w.) successfully inhibited the pentylenetetrazol-induced seizures. However, an inhibition of 30, 60 and 90% on tonic phase occurrence was observed with nantenine 20, 40 and 50 mg/kg, respectively. A significant reduction in the percentage of death in tonic (60, 90 and 100%, respectively) was also observed. (Fig. 2).
[FIGURE 2 OMITTED]
Nantenine showed a dose-dependent convulsant activity at doses ranging from 75 to 105 mg/kg. At the highest dose seizure in 100% of treated animals (latency mean time = 5.4 [+ or -] 0.5 min) was observed, followed by death on 30% of them (Fig. 3).
[FIGURE 3 OMITTED]
The previous treatment with phenobarbital 30 mg/kg and diazepam 2.5 mg/kg totally inhibited the nantenine-induced seizure. For both drugs, the inhibition was followed by 10 or more hours of sleep. It is important to emphasize that the doses of phenobarbital and diazepam used were not hypnotic by itself. After valproic acid 375 mg/kg, seizure was observed in 20% of treated animals, half of which (10%) died during the period of observation. Pretreatment with baclofen 20 mg/kg, inhibited the occurrence of seizure in 60% of animals followed by a significant increase in latency for convulsive episodes (16.75 [ + or -] 4.51 minutes) and a death percentage of 10%.
Diphenylhydantoin 25 mg/kg, (100% anticonvulsant on electroshock-induced seizures) was ineffective on inhibiting nantenine-induced seizures. On the contrary, a significant decrease in the latency for convulsive episodes (3.10 [+ or -] 0.23 minutes) was observed as well as an increase from 30 to 70 in the mortality rate (Fig. 4).
[FIGURE 4 OMITTED]
Nantenine proved to be effective in inhibiting tonic component of pentylenetetrazol-induced and maximal electroshock seizures. On the other hand, at higher doses (75, 87.5, 100 and 105 mg/kg, body w.) nantenine produced convulsive episodes, an effect that should be compared to that observed with diphenylhydantoin. Diphenylhydantoin, which was expected to inhibit nantenine-induced seizures, on the contrary, significantly reduced seizure latency and increased the mortality of animals from 30% to 70%, suggesting a synergism between the two drugs. Aside from the apparent loss of benefit when both drugs were jointly administered, nantenine and diphenylhydantoin had very similar profiles as anticonvulsant agents. At lower doses, diphenylhydantoin was effective in controlling convulsions, while at higher doses induces a toxic state characterized by irritability, ataxia and opisthotonic convulsions (Gruber et al., 1940). Much of the anticonvulsant, excitatory and toxic effects of phenytoin can be explained by its inhibitory activity on [Na.sup.+] influx, [Ca.sup.2+] uptake and action on [Na.sup.+]-[K.sup.+] active transport across excitatory tissue or epithelial cells membranes. In excitatory tissue, the greatest effect was apparently the reduction of passive [Na.sup.+] influx and/or a reduction of the [Na.sup.+] currents through voltage-dependent channels, with a consequent reduction in neuronal activity. Phenytoin may also influence the transport of [Na.sup.+] and [K.sup.+] through synaptic membranes, mainly when it is damaged, as occurs in the epileptogenic center (focus) (Escueta et al., 1971, 1974). In this case, phenytoin appears to stimulate the [Na.sup.+]-[K.sup.+] active transport, a process that similar to the reduction of [Na.sup.+] influx, increases the gradient of [Na.sup.+] across the cellular membrane, diminishes the [Ca.sup.2+] influx (Woodbury, 1980), alters the membrane potential and reduces the release of neurotransmitters (Albers et al., 1994). Its efficacy in reducing the synaptosomal release of excitatory neurotransmitters would partially explain phenytoin's anticonvulsant effects. On the other side, phenytoin may also block the release in inhibitory synapses, in such a manner that the final result will be the sum of its effects on these systems. As such, the final effect in its interaction with other drugs will also depend on the sum of effects. Similar to what occurred in the interaction with nantenine, phenytoin heightens the actions of convulsant agents, such as bicuculline and picrotoxin, which possess mechanisms involving the reduction of the inhibitory gabaergic transmission (Stone and Javid, 1982).
Recent data indicates nantenine has a dose-dependent inverse effect on the [Na.sup.+], [K.sup.+]-ATPase of synaptosomal membranes (Ribeiro and Rodriguez de Lores Arnaiz, 2000, 2001). At low concentrations, the alkaloid stimulates, whereas at high concentrations it inhibits these phosphatase. Considering the biphasic action of nantenine in seizure, the inhibition of [Na.sup.+], [K.sup.+]-ATPase could explain the convulsive effect brought on by high doses of nantenine, as such inhibition seemingly acts in countless neurotoxic processes directly or indirectly involved in convulsive activity (Lees, 1991). Conversely, the alkaloid anticonvulsant effect could be, at least in part, attributable to the stimulation of these phosphatase activity and the resultant decrease of [Ca.sup.2+]-influx into the cell (as described above to phenytoin).
Moreover, in light of the potential of aporphines and structurally related alkaloids as calcium channel blockers, one could speculate that, at lower doses, a direct inhibitory effect of nantenine on the [Ca.sup.2+] influx could be also related to the anticonvulsant effects, as well as heightening the hypnotic-sedative effects of phenobarbital and diazepam. Classic calcium channel blockers such as verapamil and nifedipine act as anticonvulsants (Czuczwar et al., 1990a, b; Kamal et al., 1990; Meyer et al., 1986) and heighten the anesthetic effects of barbiturates and benzodiazepines (Dolin and Little, 1986; Dolin et al., 1991. In addition, phenobarbital (Blaustein and Ector, 1975) and chlordiazepoxide (Leslie et al., 1980) alone also are effective in reducing the entry of voltage-dependent calcium in synaptosomes. At higher doses, the blockage of calcium influx in inhibitory synapses could contribute to the appearance of a toxic convulsive situation, which is aggravated by the interaction with diphenylhydantoin. Nevertheless, the role of changes in other regulatory mechanisms of neuronal excitability in the manifestation of convulsions should not be discarded, considering that anticonvulsants such as baclofen (which increases [K.sup.+] conductance by activation of GABAB receptors) and valproic acid (which prolongs the inactivation of the voltage-dependent [Na.sup.+] channel, increases GABA transmission through mechanisms that involve stimulation of GAD and/or inhibition of GABA-T activity) (Meldrum, 1994) reduced the percentages of convulsion and death associated with nantenine.
This research was supported by fellowship from Conselho Nacional de Pesquisa (CNPq). The authors would like to thank Mrs Teotila R. R. Amaral for capable technical assistance.
Albers RW, Siegel GJ, Stahl WL (1994) Membrane Transport. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (Eds.), Basic Neurochemistry: Molecular Cellular, and Medical Aspects. Raven Press, New York, p 49-73
Alzueta AF, Orallo F, Loza I, Gil J, Cadavid M (1992) Possible actividad [alpha]1-bloqueante y antiserotoninica de la nantenina en la aorta de rata. Revista de Farmacologia Clinica y Experimental no. esp: 305
Anselmi E, Fayos G, Blasco R, Candenas L, Cortes D, D'Ocon MP (1991) Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle. J Pharmacy and Pharmaco 144: 337-343
Baldessarini RJ, Kula NS, Zong R, Neumeyer JL (1994) Receptor affinities of aporphine enantiomers in rat brain tissue. European J Pharmacol 254: 199-203
Blaustein MP, Ector AC (1975) Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro. Molecular Pharmacol 11: 369-378
Catret M, Anselmi E, Ivorra MD (1992) Antiserotonergic effect of aporphine and benzylisoquinoline alkaloids in rat aorta. Revista de Farmacologia Clinica y Experimental no. esp: 293
Chen G; Bohner B, Ensor CR (1954) Evaluation of five methods for testing anticonvulsant activities. Proceedings of the Society for Experimental Biology and Medicine 87: 334-339
Czuczwar SJ, Chodkowska A, Kleinrok Z, Malek U, Wojtowicz EJ (1990a) Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. European Journal of Pharmacology 176: 75-83
Czuczwar SJ, Malek U, Kleinrok Z (1990b) Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology 29 (10): 943-948
Dolin SJ, Little HJ (1986) Augmentation by calcium channel antagonists of general anaesthetic potency in mice. British J Pharmaco 188: 909-914
Dolin SJ, Patch TL, Rabbani M, Tabemer PV, Little HJ (1991) Differential interactions between henzodiazepines and dihydropyridines, nitrendipine and BAY K 8644. Neuropharmacology 30(3): 217-224
Escueta AV, Reilly E (1971) The effects of diphenylhydantoin on potassium transport within synaptic terminals of 0the epileptogeulc foci. Neurology (Minneap) 21: 418
Escueta AV, Davidson D, Hartwig G, Reilly E (1974) The freezing lesion. III. The effects of diphenylhydantoin on potassium transport within nerve terminals from the primary foci. Brain Res 86: 89-96
Gruber CM, Hanry VG, Darke ME (1940) The toxic actions of sodium diphenylhydantoinate (Dilantin) when injected intraperitoneally and intravenously in experimental animals. Journal of Pharmacology and Experimental Therapeutics 68: 433-436
Ivorra MD, Lugnier C, Schott C, Catret M, Noguera MA, Anselmi E, D'Ocon MP (1992) Multiple actions of glaucine on cyclic nucleotide phosphodiesterase, [alpha]1-adrenoceptor and benzothiazepine binding site at the calcium channel. British J Pharmacol 106: 387-394
Ivorra MD, Chulia S, Lugnier C, D'Ocon MP (1993a) Selective action of two aporphines at [alpha]1-adrenoceptors and potential-operated [Ca.sup.2+] channels. European J Pharmaco 1231: 165-174
Ivorra MD, Matinez E Serrano A, D'Ocon MP (1993b) Different mechanism of relaxation by aporphine alkaloids in rat uterus. J Pharmacy and Pharmaco1 45: 439-443
Kamal JA, Nadig RS, Joseph T, David J (1990) Effect of calcium channel blockers on experimentally induced seizures in rats. Indian J Experimental Biol 28: 605-608
Lees GJ (1991) Inhibition of sodium-potassium ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res 16: 283-300
Leslie S, Friedman M, Coleman R (1980) Effects of chlordiazepoxide on depolarization-induced calcium influx in synaptosomes. Biochemical Pharmacol 29: 2439-2443
Manske RHF (1954) The aporphines alkaloids. In: Manske RHL, Holmes HL (Eds.), The alkaloids chemistry and physiology. Academic Press, New York, p. 119-145
Meldrum B (1994) Epileptic Seizures. In: Siegel GJ, Agranoff BW, Albers RW; Molinoff PB (Eds.), Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Raven Press, New York, p. 885-897
Meyer FB, Tally PW, Anderson RE, Sundt Jr TM, Yaksh TL, Sharbrough FW (1986) Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker. Brain Res 384: 180-183
Phillipson JD (1979) Natural products as a basis for new drugs. Trends in Pharmacol Sciences 1: 36-38
Ribeiro R de A, Rodriguez de Lores Arnaiz G (2000) Namenine and papaverine differentially modify synaptosomal membrane enzymes. Phytomedicine 7(4): 313-323
Ribeiro R de A, Rodriguez de Lores Arnaiz G (2001) In vitro doses dependent inverse effect of nantenine on synaptosomal membrane K-p-NPPase activity. Phytomedicine 8(2): 107-111
Shoji N, Umeyama A, Takemoto T, Ohizumi Y (1984) Serotonergic receptor antagonist from Nandina domestica Thunberg. J Pharmaceutical Sciences 73(4): 568-570
Stone WE, Javid MJ (1982) Interactions of phenytoin with ouabain and other chemical convulsants. Archives Internationaies de Pharmacodynamie 260:28-35
Swinyard EA (1972) Electrically induced seizures. In: Purpura DP, Penry JK, Tower DB, Woodbury DM, Waiter RD (Eds.), Experimental Models of Epilepsy--A Manual for the Laboratory Worker. Raven Press, New York, p. 433-458
Swinyard EA, Kupferberg JH (1985) Antiepileptic drugs: detection, quantification and evaluation. Federation Proceedings 44: 2629-2633
Takase T, Ohashi H (1926) Chemische u pharmakologische studien uber ein in den fruchten der Nandina domestica enthaltenes neues alkaloid nantenin. J Pharmacol Society Japan 535: 742-748
Woodbury DM (1980) Antiepileptic Drugs. Phenytoin: Proposed Mechanisms of Anticonvulsant Action. In: Glaser GH, Penry JK, Woodbury DM (Eds.), Antiepileptic Drugs: Mechanism of Action, Raven Press, New York, p. 447-471
Zetler G (1988) Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids, bulbocapnine, corytuberine, boldine and glaucine. Archives Internationales de Pharmacodynamie 296: 255-281
R. A. Ribeiro, Universidade Federal de Sao Paulo, Escola Paulista de Medicina, Departamento de Farmacologia, Rua Botucatu 862, Edificio Jose Leal Prado, 04023-970, Sao Paulo, SP, Brazil.
Fax: ++55-11-3064-0179; e-mail:email@example.com
R. A. Ribeiro (1) and J. R. Leite (2)
(1) Departamento de Farmacologia
(2) Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Escola Paulista de Medicina, Rua Botucatu 862, Edificio Jose Leal Prado, Sao Paulo, Brazil
|Printer friendly Cite/link Email Feedback|
|Author:||Riberio, R.A.; Leite, J.R.|
|Publication:||Phytomedicine: International Journal of Phytotherapy & Phytopharmacology|
|Date:||Jul 1, 2003|
|Previous Article:||Wound healing studies of Aristolochia bracteolata Lam. with supportive action of antioxidant enzymes.|
|Next Article:||Pharmacological and toxicological activity of Heterophyllaea pustulata anthraquinone extracts.|